CN102125676A - Traditional Chinese medicine preparation for treating fatty liver - Google Patents
Traditional Chinese medicine preparation for treating fatty liver Download PDFInfo
- Publication number
- CN102125676A CN102125676A CN 201010520098 CN201010520098A CN102125676A CN 102125676 A CN102125676 A CN 102125676A CN 201010520098 CN201010520098 CN 201010520098 CN 201010520098 A CN201010520098 A CN 201010520098A CN 102125676 A CN102125676 A CN 102125676A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine preparation
- fatty liver
- liver
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the traditional Chinese medicine preparation field, and relates to a traditional Chinese medicine preparation for treating fatty liver, which comprises, by weight, the following raw materials: 4 parts of bupleurum roots, 4 parts of curcuma longa, 3 parts of gentrin knotweed, 6 parts of white peony roots, 3 parts of hawthorn, 6 parts of salvia, 3 parts of eupatorium adenophoru, and 3 parts of peach seed. The medicine preparation of the invention has the efficacy of soothing liver and regulating qi, softening hardness and resolving blood stasis, is applicable to the treatment of fatty liver, and has the characteristics of reliable curative effect, fast effect, no side effect, safety and convenience, difficult recurrence, etc.
Description
Technical field
The invention belongs to field of traditional Chinese, particularly a kind of Chinese medicine preparation for the treatment of fatty liver.
Background technology
Fatty liver be meant fat generation in the liver surpass liver weight 35% or in the hepatocyte fatization 50% or more on the histology, according to the content of fat be divided into gently (fat content is 5%--10%), in (fat content is 10%--25%), weight (fat content is 25%--50%) spend three types of fatty livers.Primary disease belongs to the hypochondriac pain category of the traditional Chinese medical science, and how nutritious bad, the long-term excessive drinking of its cause of disease causes alcoholism and endocrinopathy etc. to influence liver and the fat metabolism of fat is deposited in the liver and causes; The traditional Chinese medical science thinks that the pathogenesis of primary disease is that surfeit delicious food, insobriety, feelings will are hindered and caused liver, spleen blood stasis, and the turbid pent-up of expectorant is treated fatty liver by the ruling by law of depressed liver-energy dispersing and QI regulating, softening and eliminating sputum in clinical and received good effect.Inventing a kind of not only safe but also effective Chinese medicine preparation is significant.
Summary of the invention
The present invention develops in conjunction with clinical practice for many years on the basis of traditional tcm treatment according to syndrome differentiation, and the treatment fatty liver has that curative effect is reliable, instant effect, have no side effect, be difficult for characteristics such as recurrence.
A kind of Chinese medicine preparation for the treatment of fatty liver of the present invention is characterized in that each raw materials in part by weight is: 3 parts in 4 parts of Radix Bupleuri, 4 parts of Radix Curcumaes, 3 parts of Rhizoma Polygoni Cuspidati, 6 parts of the Radix Paeoniae Albas, 3 parts of Fructus Crataegis, 6 parts of Radix Salviae Miltiorrhizaes, 3 parts of Herba Lycopi and Semen Persicae.
Preparation method is to take by weighing raw material by above-mentioned parts by weight, cleans roguing, dries, and rolls to be fine powder, crosses 80-100 order sieve and even pack, every bag heavy 10 gram.Warm boiled water, one time one bag, day clothes three times, 30 days is a course of treatment.
Pharmacology analysis:
Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI, ascending up spleen-Qi and Yang, treating SHAO YANG disease by mediation.This medicine is the key medicine that the treatment irritability stasis of blood stagnates, and has the effect of good dispersing the stagnated live-QI to relieve the stagnation of QI.
Radix Curcumae regulating qi to disperse stagnation, heart fire-clearing upset-relieving, promoting the function of the gallbladder to alleviate jaundice, this product pungent drugs can disperse and bitter drugs can descend, fragrance should reach, and can go into the edema caused by disorder of QI resolving depression and go into the blood system cooling blood and dissolving stasis again, are the gas medicine in the blood.
Radix Paeoniae Alba nourishing blood for regulating menstruation, suppressing the hyperactive liver pain relieving, astringing YIN to stop sweating, this product can nourishing the liver blood, hold back liver-yin, subduing the hyperfunction of the liver sun, dispersing liver-energy, anxious, the pain that relieves the pain of slow contraction, be the good medicine of treatment Liver Channel.
Rhizoma Polygoni Cuspidati promoting the function of the gallbladder to alleviate jaundice, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, expelling phlegm for arresting cough, the burnt stasis of blood is stagnant in this product bitter cold, kind the letting out, the eliminating pathogen in the liver gallbladder is damp and hot, is again that wet good medicine is mended in heat clearing away.
Hawthorn digestingization stagnates, promoting blood circulation to remove blood stasis.
Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia, relieving restlessness clears away heart-fire.
Herba Lycopi's promoting blood flow to regulate menstruation, inducing diuresis to remove edema.
Semen Persicae blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation.
The invention has the advantages that employed Chinese herbal medicine meets the Pharmacopoeia of People's Republic of China regulation, safety of medicine is reliable, all medicines are harmonious, have effects such as depressed liver-energy dispersing and QI regulating, softening hardness and resolving stasis altogether, characteristics such as the treatment fatty liver has instant effect, determined curative effect, the convenience that has no side effect, takes medicine, difficult recurrence.
Curative effect is judged:
Recovery from illness: subjective symptoms disappears, ultrasound diagnosis, and the liver of enlargement returns to normal level, and deep tissue echo is normal, and hepatic fat content is lower than 5%; Palpation does not touch liver, and the hepatic region does not have tenderness.
Take a turn for the better: subjective symptoms disappears substantially, ultrasound diagnosis, and the liver size is normal, and fat content is between 5%--10%, and the hepatic region tapping is bitterly.
Invalid: all diseases do not have improvement.
Therapeutic outcome: treatment Patients with Fatty Liver 160 examples, severe fatty liver patient 90 examples wherein, moderate Patients with Fatty Liver 70 examples, the patient takes medicine of the present invention, one time one bag, day clothes three times, 30 days is a course of treatment.Through 3 course of therapy, recovery from illness recovery from illness 80 examples account for 50%, and 80 examples that take a turn for the better account for 50%, total effective rate 100%.Shown in treatment, without any side effects to patient, three big routine tests and hepatic and renal function detect no abnormal phenomenon.
Below enumerate several model cases:
Case 1: patient Liu so-and-so, the man, 50 years old, have surplus the history of drinking history 30 year, normal sense bottom right abdominal distention and pain over 3 years does not fixingly move, the postemphasis of drinking is examined and is severe fatty liver; Oral western medicine treatment is invalid half a year, sx, and oral Drug therapy of the present invention is after three courses of treatment, the symptom complete obiteration, ultrasound diagnosis is normal, follows up a case by regular visits to not recurrence in a year.
Case 2: patient Zhang, the man, 45 years old, suffered from severe fatty liver 5 years, multi-treatment is invalid, and three recoveries from illness course of treatment of oral Drug therapy of the present invention are followed up a case by regular visits to and were not had recurrence in 1 year.
Case 3: the patient field so-and-so, the man, 52 years old, it was surplus to suffer from moderate fatty liver 6 years, three recoveries from illness courses of treatment of oral Drug therapy of the present invention are followed up a case by regular visits to and were not had recurrence in 1 year.
The specific embodiment
Embodiment:
Powder, 3 parts in 4 parts of Radix Bupleuri, 4 parts of Radix Curcumaes, 3 parts of Rhizoma Polygoni Cuspidati, 6 parts of the Radix Paeoniae Albas, 3 parts of Fructus Crataegis, 6 parts of Radix Salviae Miltiorrhizaes, 3 parts of Herba Lycopi and Semen Persicae.
Preparation method is to take by weighing raw material by above-mentioned parts by weight, cleans roguing, dries, and rolls to be fine powder, crosses 80-100 order sieve and even pack, every bag heavy 10 gram.Warm boiled water, one time one bag, day clothes three times, 30 days is a course of treatment.
Claims (1)
1. Chinese medicine preparation for the treatment of fatty liver is characterized in that each raw materials in part by weight is: 3 parts in 4 parts of Radix Bupleuri, 4 parts of Radix Curcumaes, 3 parts of Rhizoma Polygoni Cuspidati, 6 parts of the Radix Paeoniae Albas, 3 parts of Fructus Crataegis, 6 parts of Radix Salviae Miltiorrhizaes, 3 parts of Herba Lycopi and Semen Persicae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105200985A CN102125676B (en) | 2010-10-27 | 2010-10-27 | Traditional Chinese medicine preparation for treating fatty liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105200985A CN102125676B (en) | 2010-10-27 | 2010-10-27 | Traditional Chinese medicine preparation for treating fatty liver |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102125676A true CN102125676A (en) | 2011-07-20 |
| CN102125676B CN102125676B (en) | 2012-05-30 |
Family
ID=44264108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105200985A Expired - Fee Related CN102125676B (en) | 2010-10-27 | 2010-10-27 | Traditional Chinese medicine preparation for treating fatty liver |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102125676B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102441141A (en) * | 2011-11-30 | 2012-05-09 | 宋爱民 | Traditional Chinese medicine preparation for treating early cirrhosis |
| CN110946969A (en) * | 2019-12-23 | 2020-04-03 | 河南中医药大学第一附属医院 | Traditional Chinese medicine preparation for enhancing the antiviral efficacy of entecavir in CHB combined with NAFLD, its preparation method and combination therapy drug |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1524540A (en) * | 2003-02-28 | 2004-09-01 | 唐山康琳药业有限公司 | Chinese medicine preparation for treating fatty liver and its preparation method |
| CN101401920A (en) * | 2008-11-06 | 2009-04-08 | 张晨 | Traditional Chinese medicine preparation for treating fatty liver |
-
2010
- 2010-10-27 CN CN2010105200985A patent/CN102125676B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1524540A (en) * | 2003-02-28 | 2004-09-01 | 唐山康琳药业有限公司 | Chinese medicine preparation for treating fatty liver and its preparation method |
| CN101401920A (en) * | 2008-11-06 | 2009-04-08 | 张晨 | Traditional Chinese medicine preparation for treating fatty liver |
Non-Patent Citations (2)
| Title |
|---|
| 《山东中医杂志》 20020731 曲修好，赵晓珍 降脂复肝汤治疗脂肪肝50例 407-408 1 第21卷, 第7期 * |
| 《山东中医杂志》 20020731 曲修好，赵晓珍 降脂复肝汤治疗脂肪肝50例 407-408 1 第21卷, 第7期 2 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102441141A (en) * | 2011-11-30 | 2012-05-09 | 宋爱民 | Traditional Chinese medicine preparation for treating early cirrhosis |
| CN102441141B (en) * | 2011-11-30 | 2014-03-05 | 宋爱民 | Traditional Chinese medicine preparation for treating early hepatocirrhosis |
| CN110946969A (en) * | 2019-12-23 | 2020-04-03 | 河南中医药大学第一附属医院 | Traditional Chinese medicine preparation for enhancing the antiviral efficacy of entecavir in CHB combined with NAFLD, its preparation method and combination therapy drug |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102125676B (en) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101890133B (en) | Medicine for lowering high blood pressure | |
| CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
| CN103272096A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
| CN103920074A (en) | Traditional Chinese medicine composition for treating hepatitis B | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN101361949B (en) | Traditional Chinese medicine for treating gynaecologic emmeniopathy | |
| CN102302733B (en) | Oral Chinese medicinal composition for treating ovarian cyst | |
| CN102125676B (en) | Traditional Chinese medicine preparation for treating fatty liver | |
| CN101342249B (en) | Chinese medicine formulations for treating hepatitis B and preparation method thereof | |
| CN102091288A (en) | Chinese medicine preparation for treating fatty liver and preparation method thereof | |
| CN102125621B (en) | Traditional Chinese medicine preparation for treating senile constipation | |
| CN105250954B (en) | A kind of Chinese medicine for treating IBS and preparation method thereof | |
| CN102133314B (en) | Chinese medicinal preparation for treating ulcerative colitis | |
| CN105878829A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN101411770A (en) | Medicament for treating blood stasis accumulation type multiple sclerosis symptoms | |
| CN101095810B (en) | Decoction medicine for treating seborrhoeic dermatitis and method for preparing the same | |
| CN101700335B (en) | Traditional Chinese medicinal preparation for treating chronic appendicitis | |
| CN102125627B (en) | Traditional Chinese medicine preparation for treating chronic pelvic inflammation | |
| CN103933408A (en) | Traditional Chinese medicinal decoction for treating acute gouty arthritis | |
| CN103566311A (en) | Traditional Chinese medicine composition used for curing biliary tract ascariasis | |
| CN106266971A (en) | A kind of pharmaceutical preparation for treating cyclomastopathy | |
| CN103520403B (en) | Traditional Chinese medicine for treating type II diabetes | |
| CN104958638A (en) | Traditional Chinese medicine for treating liver-kidney yin deficiency type hemicrania and preparation method for traditional Chinese medicine | |
| CN102125677B (en) | Traditional Chinese medicine preparation for treating acute cholecystitis | |
| CN103301434A (en) | Traditional Chinese medicine for treating equine intestinal spasm |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUDONG TECHNOLOGY CENTER Free format text: FORMER OWNER: SONG AIMIN Effective date: 20131206 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 256100 ZIBO, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131206 Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee after: Rudong science and Technology Center Address before: 256100 Yiyuan people's Hospital, Zibo, Shandong, China Patentee before: Song Aimin |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200421 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee before: Rudong science and Technology Center |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20211220 Address after: Fengli town Xinjian West Road, Rudong County, Nantong City, Jiangsu Province 226400 Patentee after: Rudong Wenyuan investment and Development Co.,Ltd. Address before: 226400 No.10 Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 |